Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel in Japanese Pediatric Atopic Dermatitis (Extension)
NCT00231998Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of pimecrolimus in atopic dermatitis (AD), sponsored by Novartis. Started May 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00231998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231998.